和瑞基(ji)(ji)因(yin)作為貝瑞基(ji)(ji)因(yin)成(cheng)員(yuan)企(qi)業創立于(yu)(yu)2017年(nian),是一(yi)家專注(zhu)腫(zhong)(zhong)(zhong)(zhong)瘤(liu)(liu)全(quan)病程的(de)基(ji)(ji)因(yin)檢(jian)(jian)測(ce)公(gong)司,在(zai)(zai)“一(yi)切腫(zhong)(zhong)(zhong)(zhong)瘤(liu)(liu)實現早診早治,所有患(huan)者獲得較(jiao)好治療(liao)”的(de)使命下,建立了針(zhen)對腫(zhong)(zhong)(zhong)(zhong)瘤(liu)(liu)中(zhong)晚期患(huan)者治療(liao)的(de)完整(zheng)基(ji)(ji)因(yin)檢(jian)(jian)測(ce)產品服(fu)務(wu)體系(xi)(xi):包(bao)括靶(ba)向與免疫用藥(yao)檢(jian)(jian)測(ce)、療(liao)效監測(ce)、預后判(pan)斷(duan)等系(xi)(xi)列(lie)產品;同時,在(zai)(zai)腫(zhong)(zhong)(zhong)(zhong)瘤(liu)(liu)早期篩查(cha)診斷(duan)領域(yu),啟(qi)動了包(bao)括肝(gan)癌、肺癌、婦(fu)科腫(zhong)(zhong)(zhong)(zhong)瘤(liu)(liu)等一(yi)系(xi)(xi)列(lie)早篩早診臨床(chuang)研究項目(mu);完成(cheng)了兩(liang)地(福(fu)州、北京)三中(zhong)心(實驗、超算、研發)的(de)布局(ju);著力于(yu)(yu)為臨床(chuang)腫(zhong)(zhong)(zhong)(zhong)瘤(liu)(liu)治療(liao)和個人(ren)健康管理(li)提供更好的(de)腫(zhong)(zhong)(zhong)(zhong)瘤(liu)(liu)基(ji)(ji)因(yin)檢(jian)(jian)測(ce)服(fu)務(wu),合作和服(fu)務(wu)網絡(luo)覆蓋全(quan)國(guo)400多家三甲醫院,已為數十萬腫(zhong)(zhong)(zhong)(zhong)瘤(liu)(liu)患(huan)者提供了有價值(zhi)的(de)腫(zhong)(zhong)(zhong)(zhong)瘤(liu)(liu)基(ji)(ji)因(yin)檢(jian)(jian)測(ce)服(fu)務(wu)。